Rethinking Preclinical Technologies for Cell and Gene
November 17, 2025
Digital tools, live imaging, and molecular engineering are pushing the boundaries of what’s possible in preclinical development
8 min read
False
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.
All the latest Medicine Maker articles.
November 12, 2025
Engineered tRNAs are redefining precision RNA therapeutics, restoring protein function in diseases caused by nonsense mutations, and bridging the gap between RNA and gene editing technologies.
5 min read
November 12, 2025
Our latest news roundup reports on Novartis’ new radioligand facility in California, new tech for boosting AAV yields, and MeiraGTx’s deal with Eli Lilly
4 min read
November 11, 2025
Interim results from a clinical trial addressing a fatal brain matter disorder suggest that gene therapy could be an effective approach
3 min read
November 11, 2025
Drug manufacturing is under pressure as biologics become more complex. To simplify progress, cell line development is evolving with AI and automation.
7 min read
November 11, 2025
Lyell Immunopharma acquires rights to CAR T cell therapy for solid tumors
2 min read
November 10, 2025
Expanded collaboration between Recipharm Advanced Bio and the UK’s University of Oxford targets vaccine candidates for malaria
4 min read
November 10, 2025
Pharma must break down data silos to power autonomy, speed, and improved product quality.
3 min read
November 7, 2025
Experts discuss in vivo CAR T cell therapy, gene therapies for CNS diseases, personalized cancer vaccines and more.
1 min read
November 6, 2025
An invitation to our readers to feed back on our content
1 min read
November 5, 2025
Tidmarsh reportedly resigns from FDA and Aurinia Pharmaceuticals files lawsuit
2 min read
False